Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
April 23, 2024
-Factor to reveal novel mRNA-engineered immunosuppressive allogeneic cells. -Presentations will include latest data from Factor’s library of novel ionizable lipids, including delivery of mRNA to T cells and monocytes. -Factor to present progress on multi-cell type iPS cell strategy for solid-tumor targeting, including mRNA engineering for enhanced cancer-cell killing. CAMBRIDGE, Mass., April 23, 2024 /PRNewswire/ […]